The impact of an automatic syringe dispensing machine in inner‐city Sydney, Australia: No evidence of a ‘honey‐pot’ effect

Day, Carolyn; White, Bethany; Haber, Paul

doi:10.1111/dar.12397

Cited by 10 publications

(16 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In one study, constituencies reported barriers as current political climate, lack of community level preparation, and cultural context [23]. PHVM are not associated with increases in crime rates, nor has loitering or related activity been observed [24].…”

Section: Acceptability (Participant Perspectives)mentioning

confidence: 99%

A scoping review of implementation considerations for Harm Reduction Vending Machines

Russell

Johnson

Kosinski³

et al. 2022

Preprint

View full text Add to dashboard Cite

Background Community-based harm reduction vending machines (HRVM) are not new to the field of public health; numerous countries have implemented them in response to the needs of people who use drugs over the last three decades. However, until recently, few existed in the United States. Given the rapidity with which communities are standing up harm reduction vending machines, there is a pressing need for a consolidated examination of implementation evidence. This scoping review summarizes existing literature using multiple implementation science frameworks. Methods The scoping review was conducted in five stages including 1) Identify the research question; 2) Identify relevant studies; 3) Select the publications based on inclusion/exclusion criteria; 4) Review and extract data; and, 5) Summarize results. PubMed, Embase, and Web of Science were searched and authors screened publications in English from any year. Data were extracted by applying implementation constructs from RE-AIM and the Consolidated Framework for Implementation Research (CFIR). Both frameworks provided a useful lens through which to develop knowledge about the facilitators and barriers to HRVM implementation. The review is reported according to PRISMA guidelines. Results After applying the full inclusion and exclusion criteria, including the intervention of interest (“vending machines”) and population of interest (“people who use drugs”), a total of 23 studies were included in the scoping review. None of the studies reported on race, making it difficult to retroactively apply a racial equity lens. Among those articles that examined effectiveness, the outcomes were mixed between clear effectiveness and inconclusive results. Evidence emerged, however, to address all CFIR constructs, and positive outcomes were observed from HRVM’s after-hour availability and increased program reach. Recommendations: HRVM implementation best practices include maximizing accessibility up to 24 hours, 7 days a week, offering syringe disposal options, ensuring capability of data collection, and allowing for anonymity of use. Organizations that implement HRVM should establish strong feedback loops between them, their program participants, and the broader community upfront. Considerations for future research include rigorous study designs to evaluate effectiveness outcomes (e.g. reduced drug overdose deaths) and examination of HRVM reach among ethnic and racial communities.

show abstract

Section: Acceptability (Participant Perspectives)mentioning

confidence: 99%

A scoping review of implementation considerations for Harm Reduction Vending Machines

Russell

Johnson

Kosinski³

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Several studies have shown that some people who use ADMs differ from those who access face-to-face NSPs or pharmacies for injecting equipment, reporting that primary ADM users were younger, had shorter durations of injecting, injected less frequently, were less likely to report risky injecting practices or to have received opioid agonist treatment (OAT) [ 5 , 7 , 17 , 18 ]. However, two recent Australian studies suggested that when ADMs were located adjacent to face-to-face NSPs and near pharmacies, the ADM was primarily used by clients of face-to-face services who used the ADM outside business hours [ 19 , 20 ].…”

Section: Introductionmentioning

confidence: 99%

Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study

Coupland

Henderson²,

Pritchard-Jones

et al. 2022

Harm Reduct J

Self Cite

View full text Add to dashboard Cite

Background Global commitment to achieving hepatitis C virus (HCV) elimination has enhanced efforts in improving access to direct-acting antiviral (DAA) treatments for people who inject drugs (PWID). Scale-up of efforts to engage hard-to-reach groups of PWID in HCV testing and treatment is crucial to success. Automatic needle/syringe dispensing machines (ADMs) have been used internationally to distribute sterile injecting equipment. ADMs are a unique harm reduction service, affording maximum anonymity to service users. This paper explores the feasibility and acceptability of extending the HCV cascade of care to sites where ADMs are located. Methods The ADM users into Treatment (ADMiT) study was undertaken in a metropolitan region in Sydney, Australia. This mixed methods study involved analysis of closed-circuit television footage, ethnographic methods (fieldwork observation and in-depth interviews) and structured surveys. Researchers and peers conducted fieldwork and data collection over 10 weeks at one ADM site, including offering access to HCV testing and treatment. Results Findings from 10 weeks of fieldwork observations, 70 survey participants and 15 interviews highlighted that there is scope for engaging with this population at the time they use the ADM, and enhanced linkage to HCV testing and treatment may be warranted. Most survey participants reported prior HCV testing, 61% in the last 12 months and 38% had received HCV treatment. However, fieldwork revealed that most people observed using the ADM were not willing to engage with the researchers. Field work data and interviews suggested that extending the HCV cascade of care to ADMs may encroach on what is a private space for many PWID, utilized specifically to avoid engagement. Discussion Enhanced linkage to HCV testing and treatment for people who use ADMs may be warranted. However, data suggested that extending the HCV cascade of care to ADMs may encroach on what is a private space for many PWID, utilized specifically to avoid engagement. The current study raises important public health questions about the need to ensure interventions reflect the needs of affected communities, including their right to remain anonymous.

show abstract

“…The community response to this announcement was reported in the local print and state-wide radio and television media (Channel 10 News, 2013;Day et al, 2014;Fordham, 2013aFordham, , 2013bFordham, , 2013cFordham, , 2013dWhite et al, 2014). Media attention was largely focused on perceptions of a "honey-pot" effect, a perceived increased in crime, reduced public amenity and a poor understanding of the aims of harm reduction imbued with a sense of NIMBYism ('not in my back yard'), remarkably similar to that described by Davidson and Howe (2014).…”

Section: Introductionmentioning

confidence: 99%

Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia

White

Haber

Day

2016

International Journal of Drug Policy

Self Cite

View full text Add to dashboard Cite

The impact of an automatic syringe dispensing machine in inner‐city Sydney, Australia: No evidence of a ‘honey‐pot’ effect

Cited by 10 publications

References 18 publications

A scoping review of implementation considerations for Harm Reduction Vending Machines

A scoping review of implementation considerations for Harm Reduction Vending Machines

Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study

Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia

Contact Info

Product

Resources

About